It appeared that combination of amivantamab and pembrolizumab significantly enhanced infiltration of granzyme B–producing CD8 T cells was in the TME of HNSCC PDX (P < 0.01) and enhanced neoantigen-associated central memory CD8 T cells in circulating immune cells. The gene discussed is GZMB; the disease is head and neck squamous cell carcinoma.